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ABSTRACT 
Background/Aims: Hepatocellular carcinoma (HCC) patients often have 
esophago-gastric varices due to portal hypertension by chronic hepatitis or cirrhosis. 
Surgical treatment for gastric varices is necessary when the patient undergoes hepatic 
resection for HCC, simultaneously.  Methodology: We examined the clinical 
demographics, surgical records and outcome in 7 patients undergoing both hepatectomy 
and Hassab’s operation (=decongestion of upper gastric veins and splenectomy) between 
1994 and 2007. Results: All patients had HCC, including chronic injured liver diseases. 
Preoperative liver functions were well preserved in all patients. Right hepatectomy was 
performed in two patients and limited resections in 5. Three patients had postoperative 
complications and the in-hospital death by hepatic failure was observed in one. Four 
patients had tumor recurrence within one year and 3 were dead, while, two patients had 
long-term survival with or without recurrence of HCC. Following Hassab’s operation, 
gastric varices dramatically disappeared. Portal hypertension and hypersplenism were 
significantly improved. Conclusions:  Simultaneous operation with Hassab’s procedure 
and hepatectomy is useful and can be safely performed in HCC patients with gastric 
varices. 
 
KEYWORDS: hepatocellular carcinoma, hepatectomy, gastric varix, Hassab’s operation 
ABBREVIATIONS: hepatocellular carcinoma (HCC), indocyanine green retention rate 
at 15 minutes (ICGR15) 
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INTRODUCTION 
Hepatocellular carcinoma (HCC) patients often have esophago-gastric varices due to 
portal hypertension caused by injured liver such as chronic viral hepatitis and cirrhosis (1, 
2). Esophageal varices are usually treated using endoscopic procedures such as 
sclerotherapy or ligation technique (3). When surgical treatment is scheduled, large 
varices or veins with red color should be treated with endoscopy prior to operation to the 
reduce risk of postoperative hemorrhage (4). However, in case of gastric varices, 
endoscopic treatment may be difficult and surgical removal of varicose veins in the upper 
stomach is more effective than other modalities (5). Therefore, simultaneous treatments 
such as a Hassab’s operation (=decongestion of upper gastric marginal veins and 
splenectomy) with treatments for HCC should be necessary (6, 7). In the present report, 
we examined the clinical demographics, surgical records and outcome in 7 HCC patients 
with gastric varices who underwent simultaneous hepatectomy concomitant with 
Hassab’s operation in the Division of Surgical Oncology, Department of Translational 
Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences 
(NUGSBS) between 1994 and 2007. 
 
CASES 
       Between 1994 and 2007, Hassab’s operation was performed in 10 patients with 
gastric varices, and 7 of 10 patients had HCC simultaneously. Patients included 3 men 
and 4 women with ages ranging from 54-77 years (Table 1).  All patients had HCC with 
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background liver disease; one patient had chronic viral hepatitis, one had primary biliary 
cirrhosis and 5 had cirrhosis by viral hepatitis. Child-Pugh classification A was present in 
5 patients and B in two. Only one patient had a history of hematemesis and a routine 
gastroscopy found gastric varices in other patients. Tumor-node-metastasis stage I was 
found in one patient, II in one, III in 4, and IVA in one (8). Table 2 shows the operative 
procedures and patient outcomes. All patients underwent decongestion of the upper 
gastric marginal veins and splenectomy for gastric varices prior to hepatic resections. 
Right hepatectomy was undertaken in two patients and limited resections were performed 
in 5 patients for HCC. Blood loss ranged between 516 and 2960 mL (mean; 1290±947 
mL) and 3 patients needed red cell transfusion. Three patients had postoperative 
complications and in-hospital death from hepatic failure occurred in one patient who 
underwent limited resection. Four patients had a recurrence of HCC and 3 patients died 
from tumors. Two patients had a long-term survival and one patient had no tumor 
recurrence. Findings of gastric varices are shown in Table 3. Six patients showed white 
varix and two patients showed red color sign. Six patients had esophago-gastric varix and 
all patients had large varices. Follow-up gastroscopy at one month after operation could 
be performed in 6 patients and varices completely disappeared in 5 patients and one 
showed a mild esophageal varix. Figure 1 shows the changes of laboratory data before 
and after operation. Portal pressure was significantly decreased and indocyanine green 
retention rate at 15 minutes (ICGR15) was significantly increased. White blood cell 
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tended to be increased but the change was not significant. Platelet count was significantly 
increased after operation. 
          
DISCUSSION 
          In the long history of treatment for gastric varices due to portal hypertension in 
cirrhotic patients, the usefulness of Hassab’s operation has been well recognized, as 
reported previously (5-7). The operative procedure is safe and gastric varices outcome is 
positive. Cirrhotic patients often have simultaneous HCC, which must be treated. Hepatic 
resection is still the most useful option for radical treatment of HCC compared to ablation 
therapy or chemoembolization (9). Therefore, when it is necessary to treat gastric varices 
under laparotomy, simultaneous hepatic resection for HCC would be reasonable. 
Although there is the risk of liver failure in cases of simultaneous operation in cirrhotic 
patients, previous reports showed the safety and usefulness for this procedure (6, 7). 
       In the present report, liver function in all patients was well preserved, even in 
cirrhotic livers. Hepatectomy indication was based on Makuuchi’s criteria (10) and, 
therefore, preoperative conditions of total bilirubin level less than 2.0 mg/dl, ICGR15 less 
than 40% and no intra-abdominal ascites were basically necessary in the present 
procedure. If liver function worsens, other modalitis for HCC treatment can be selected. 
In the present series, the preoperative platelet count was lower than 100,000/mm3 as 
shown in the figure due to hypersplenism caused by portal hypertension. This parameter 
is important before hepatectomy to care for intra- or post-operative bleeding tendency 
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and hepatic failure (11). We preferably apply splenectomy prior to hepatectomy in 
patients with a low level of platelet count by hypersplenism. Splenectomy in Hassab’s 
operation is also variable to prevent the above complications. Hematemesis as an onset of 
finding gastric varices rarely occurred and routine gastroscopy for liver diseases was 
useful as in previous reports (12).  
       Major hepatectomy could be performed in 2 patients because of strong liver function. 
We propose that the indication of hepatectomy is not limited by the presence of gastric 
varix. Hassab’s operation was completed in all patients without massive bleeding and, 
therefore, this procedure can be safely performed regardless of treatment for veins with 
portal hypertension. Four patients who underwent partial hepatectomy did not need 
intraoperative blood transfusion. On the other hand, two of three patients requiring red 
cell transfusion underwent major hepatectomy; however, these transfusion were limited 
to within 800 mL. In summary, simultaneous Hassab’s operation and hepatectomy was 
safely performed in all patients in the present study.  Postoperative outcomes were 
satisfactory, except for one patient who died due to uncontrolled ascites and subsequent 
liver failure. This patient had liver function of Child-Pugh B, ICGR15 38%. The 
uncontrolled ascites can be predicted by the serum hyaluronic acid (HA) level by our 
study at this stage (13); however, this parameter was not examined at the time of 
treatment for this patient. If the serum HA level was at a high level, ablation or 
chemoembolization might have been selected. Long-term prognosis was not well 
satisfied because of early recurrence in HCC patients with TNM stage III and IVA in our 
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series. We are not sure whether splenectomy influenced the immune-response to tumor 
recurrence in our series; however, it is speculated that splenectomy was associated with 
immune-deficiency for cancer progression (14).  
        Our recent result showed that massive gastric varices were successfully treated 
except in one case. Hassab’s operation was dramatically effective. Only one patient had a 
mild esophageal varix, which was easily controlled followed with endoscopic ligation. 
This effect has been maintained for a long period in all patients, as in previous reports (5, 
6). Following splenectomy, hypersplenism, portal flow or pressure may improve as 
reported previously (15). In the present study, portal pressure dramatically decreased 
immediately after splenectomy during operation. Lower white cell count or platelet count 
were significantly improved after splenectomy as well. Increase of platelet count is an 
advantage for following hepatectomy to reduce risk of hepatic failure. However, the 
result of ICGR15 became worse; this change might be influenced by hepatectomy. 
In conclusion, we examined 7 patients with HCC patients with gastric varices who 
were treated with simultaneous Hassab’s operation and hepatic resection. Six patients 
safely underwent these operations but one patient died of massive ascites and 
postoperative hepatic failure. Gastric varices, portal hypertension and hypersplenism 
were well controlled by Hassab’s operation; however, tumor recurrence was still 
aggressive after operation. Two patients had long-term survival. Simultaneous operation 
of Hassab’s procedure and hepatectomy can be usefully and safely performed in patients 
with HCC patients with gastric varices. 
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FIGURE LEGEND 
FIGURE 1  Changes of laboratory data before and after operation. Preop.; preoperation. 
Postop.; postoperation. 
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TABLE 1 Clinical Demographics of Patients 
 
Case Age Gender Background liver Viral status 
Child-Pugh 
classification 
History of  
hematemesis 
Japanese TNM  
stage of HCC* 
1 63   Female Cirrhosis hepatitis C A No I 
2 77   Female Cirrhosis hepatitis C B No III 
3 67   Male Chronic hepatitis hepatitis B 
A No III 
4 66   Female Cirrhosis hepatitis C 
A No III 
5 73  Female PBC none 
A Yes II 
6 54   Male Cirrhosis hepatitis B A No IVA 
7 57   Male Cirrhosis hepatitis C 
B No III 
*: 
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TABLE 2 Operative Procedures and Outcomes 
 




1 Limited resection (S6)* 600 Mild ascites Survival with tumor recurrence (146)# 
2 
Limited resection  




Dead by liver failure (2) 
3 Right hepatectomy 2686 None Dead by tumor (13) 
4 Limited resection (S8) 885 None Dead by tumor (5) 
5 Limited resection (S5) 1337 None Survival without tumor recurrence (98) 
6 Right hepatectomy 2960 Mild ascites Dead by tumor (15) 
7 Limited resection (S8) 1550 None Survival with tumor recurrence (9) 
*: parenthesis shows segment of the liver.  
#: months after operation 
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TABLE 3 Findings of Gastric Varices (16) 
 




Changes after Hassab’s operation 
at 1 month after operation 
1 Blue negative  Lm* 3 Disappeared 
2 Blue negative Lm 2 Disappeared 
3 Blue negative Lm 2 Disappeared 
4 White negative Li# 2 
Disappeared 
5 Blue negative Lm 2 Disappeared 
6 Blue positive - 3 Disappeared 
7 Blue positive Li 2 Mild esophageal varix 
 
*: Middle esophagus 
            #: Inferior esophagus 
             
P=0 0071 P=0 03526
60
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